You are invited to ISAC's next free webinar on:
Advances in non tuberculous mycobacteria and new risks for public health
21 January 2025
10.00 - 11.00 CET*
ISAC invites you to a compelling webinar on Advances in Non-Tuberculous Mycobacteria and Emerging Public Health Risks. Dr Emmanuelle Cambau will provide an insightful overview of non-tuberculous mycobacteria, highlighting what’s new on the horizon, while Dr Jakko van Ingen will present an update on the diagnosis and treatment of Mycobacterium abscessus infections which are increasing particularly in immunocompromised patients or those with comorbidities. This is a must-attend event for anyone interested in the latest developments and challenges in this evolving field.
*Find your start time by time zone
Speakers
Dr Emmanuelle Cambau
"Overview on non-tuberculous mycobacteria: what is new on the horizon"
Emmanuelle CAMBAU is a medical doctor specialized in clinical microbiology working at the University of Paris and Hospitals of Paris (France). She had studied bacterial antimicrobial resistance for many years. She is involved in the microbial diagnosis of mycobacterial infections such as tuberculosis, leprosy and those due to nontuberculous mycobacteria. She is the head of one of the two labs for the French reference center for mycobacteria in France and a National focal point for tuberculosis for Europe, member of the ECDC network ERLTB net. Her international duties and positions were first to create a Study group on mycobacterial infections (ESGMYC) for the European society for clinical microbiology and infectious diseases (ESCMID) and chair it from 2011 to 2016, and second to create the EUCAST subcommittee for antimycobacterial susceptibility testing that she is chairing since 2016. She was elected for two terms as a member of the Executive Committee of the European society for clinical microbiology and infectious diseases (ESCMID) since May 2018. Her third main international activity is being a member of the WHO Technical advisory group for Global Leprosy Program since 2013, and co-leading the WHO network for surveillance of resistance in leprosy since 2008.
Prof. Jakko van Ingen
"Update on diagnosis and treatment of M. abscessus infections"
Jakko van Ingen, MD, PhD, is a consultant clinical microbiologist and head of the mycobacteriology reference laboratory at Radboud University Medical Center in Nijmegen, the Netherlands. He has authored over 250 papers on mycobacterial disease in peer-reviewed scientific journals and is consulted on diagnosis and treatment of tuberculosis and nontuberculous mycobacterial disease from all over the world. His research group focuses on the pharmacodynamics of antimycobacterial drugs and development of new treatment regimens for tuberculosis and nontuberculous mycobacterial disease.
Prof. Souha Kanj
Prof. Souha Kanj is currently a tenured Professor of Medicine, Head of the Division of Infectious Diseases (ID), Chair of the Infection Control (IC) Program and co-Chair of the Antimicrobial Stewardship (AMS) Program at the American University of Beirut Medical Center, Lebanon. She is Consultant Professor at Duke University Medical Center, USA.
She has co-authored 300 papers in peer reviewed journals, several book chapters and UpToDate® cards. She has contributed to the work of WHO in various programmes.
Professor Kanj is a fellow of the ACP, IDSA, RCP, ESCMID, and ECMM. She is currently President of ISAC and President of the Lebanese Society for Infectious Diseases and Clinical Microbiology.
Professor Kanj has been the recipient of numerous honours and awards and an honorary degree from Radboud University in 2020.
Prof. David Jenkins
Dr David Jenkins is a consultant medical microbiologist at University Hospitals of Leicester NHS Trust, where he has been the infection prevention lead doctor for the last 25 years as well as antimicrobial stewardship lead. He is also an honorary associate professor at Leicester University and, between 2021-2024, the president of the British Society for Antimicrobial Chemotherapy. His interests include behavioural aspects of antimicrobial prescribing and stewardship as well as data analysis and policy development. Prof. Jenkins is ISAC's Treasurer.
